Precision mycoingredients
Medicinal mushrooms cultivated in controlled bioreactors — delivering verified, high-concentration bioactives for supplements, functional food, and cosmetics. Every batch HPLC-confirmed.
The problem we solve
The nutraceutical industry sells on a quiet assumption: that a "10:1 extract" ratio means something. It doesn't. It tells you nothing about the concentration of the compound that drives the biological effect.
Most reishi on the market has never been tested for ganoderic acids. Most lion's mane has never been tested for erinacine A. Most cordyceps contains less than 0.5% cordycepin — the active nucleoside responsible for every documented benefit.
Longevity Lab was built to fix this. Closed-loop bioreactors. Optimised fermentation conditions per species. HPLC-verified concentration on every batch, before every shipment.
The portfolio
Each species cultivated in dedicated bioreactor conditions. Full research briefs available on request.
Markets served
Select a market to see which species are best positioned — based on documented clinical outcomes and bioactive profiles.
Only ingredient with HPLC-verified 6% cordycepin. Enables specific mg/serving claims. Human RCTs for NK cell activation and CKD support.
5 human RCTs with cognitive endpoints. Erinacine A quantified per batch. Stack with Reishi for brain + longevity formula.
38 human clinical studies. Sleep mechanism documented. FSGS nephropathy and LUTS improvement in human RCTs.
Highest antioxidant activity of any mushroom. Anti-tumour triterpenoid data. Bioreactor eliminates the oxalate nephropathy risk of wild Chaga.
Antroquinonol is a Phase 2 clinical drug candidate. NASH human RCT (6 months). Phase 1 immune activation trial.
Sustainable alternative to critically endangered wild species. VO2 threshold improvement RCT (12 weeks). Kidney protection with RCT evidence.
AMPK activation supports energy and endurance positioning. Anti-fatigue pathway confirmed. Human stem cell recruitment post-exercise verified.
Acute cognitive performance data (Stroop task, 2023 RCT). "Brain food" positioning with 5 human RCTs.
Water-soluble polysaccharides integrate cleanly with neutral flavour. Gut microbiota modulation supports prebiotic co-positioning.
Established consumer ingredient. Bioreactor extract is safer and cleaner than wild-harvested. Neutral, slightly earthy flavour.
VO2 and endurance data for sports drink positioning. Sirtuin activation (NAD+) for longevity beverage claims.
Rare Taiwan endemic — compelling provenance for premium brands. Liver-protective fractions for detox and liver support formats.
UV-induced carcinogenesis reduction (PLoS One, 2022). Polysaccharides for skin barrier and hydration.
NGF stimulation supports skin cell renewal. Beta-glucan hydrogel wound-healing data (2024). Anti-inflammatory polysaccharides.
Human RCT: topical Cordyceps comparable to hydroquinone for melasma (2025). Rare clinical skin data in the mushroom category.
Photoaging reversal via Nrf2/autophagy. UVB DNA damage protection. Premium "forest antioxidant" story.
Antcin M reverses hyperglycemia-accelerated skin aging via Nrf2/SIRT-1. Ergostatrien-3beta-ol shows UV-photoprotection. Taiwan provenance.
NAD-driven sirtuin activation supports skin longevity claims. Dry eye human RCT (70 subjects) supports ophthalmic positioning.
Antroquinonol Phase 2 clinical candidate. Human NASH RCT (28 patients, 6 months). Phase 1 immune activation trial well-tolerated to 2988 mg/day.
Two RCTs for FSGS nephropathy. Two RCTs for lower urinary tract symptoms in men. Colorectal adenoma suppression in controlled trial.
Human clinical trial evidence for CKD (3 months). Anti-PD1 augmentation data. COPD animal models.
Renal transplant adjunct RCT (reduced CNI dosing). COPD exacerbation reduction RCT (240 patients). Dry eye RCT (70 subjects).
Strongest neurological evidence base of any mushroom. 5 human RCTs. Depression reduction RCT. Erinacine A quantified per batch.
Renal fibrosis and diabetic nephropathy preclinical data. Human ex vivo IBD antioxidant DNA protection. Broad antiviral profile.
How it works
Why source from us
Active compound concentration confirmed analytically before every shipment. Not an extract ratio — actual bioactive content. COA per batch, HPLC data on request.
"10:1 extract" tells you nothing about biological activity. Longevity Lab specifies the compound that drives the effect — so every mg on your label is defensible.
Same bioactive profile, every batch. Field-grown mushrooms vary up to 10× between harvests. Consistent extract means consistent products and stable claims.
Patent filed 2025 (WO2023180197A1). You are sourcing from the inventor of the method — not a commodity broker re-selling variable field extract.
Every batch traceable from authenticated strain bank to finished extract. Supports regulatory submissions, clinical studies, or retailer audits.
One bioreactor replaces 500 m² of agricultural cultivation. No land use, no pesticides, no endangered species, no seasonal dependency.
Scientific backing
NK cell activity and Th1 immune response significantly enhanced in 79 healthy men after 4 weeks of supplementation.
J Med Food · PMID 26284906
Acute supplementation improved Stroop task speed and reduced psychological stress in 41 healthy adults.
Nutrients · PMID 38004235
Spore oil reduced triglycerides in adults with elevated levels — crossover design.
Nutrients · PMID 40077714
Mycelium extract improved NASH steatosis and reduced TNF-alpha over 6 months in 28 patients.
J Am Coll Nutr · PMID 32657670
INO10 extract alleviated Alzheimer's pathology and cognitive deficits in 3xTg-AD transgenic mice.
Int J Mol Sci · PMID 40429872
Cordycepin modulates microglial M2 polarisation via HKII/PDK2 — neuroinflammation suppression mechanism confirmed.
Adv Sci · PMID 38889331
The team
Work with us
We work with supplement, functional food, and cosmetic brands from ingredient selection to formulation support. Tell us about your project.
Ingredient enquiry